Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
In the thyroid, however, the situation is different
On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
Other GI monitored (diarrhoea, reflux, dyspepsia) Beyond nausea, vomiting, and constipation, the clinical trials of retatrutide also monitored a range of other gastrointestinal (GI) side effects
Vaccine efforts are under way in several neglected diseases, too
Ive covered more recent nonsensical attempts to slow aging with everything from royal jelly and megadoses of vitamins to colloidal silver, testosterone-boosting plant extracts and growth hormone injections
